Both domains, a and ,, of the cytoplasmic membrane-localized Tet proteins encoded by the tet gene family (classes A through E) are required for resistance to tetracycline (Tcr) in gram-negative bacteria. Two inactive proteins, each containing a mutation in the opposite domain, are capable of complementation to produce Tcr. Similarly, inactive hybrid proteins expressed by interdomain gene hybrids constructed between tet(B) and tet(C) [tet(B)aI(C)P and tet(C)aI(B),I] together produce significant Tcr via trans complementation (R. A. Rubin and S. B. Levy, J. Bacteriol. 172:2303Bacteriol. 172: -2312Bacteriol. 172: , 1990. A derivative of tet(B) was constructed to express the two domains of Tet(B) as separate polypeptides, neither containing intact the central, hydrophilic interdomain region. Cells harboring this tet(B) mutant expressed Tcr at about 20% the level conferred by intact tet(B). As expected, no detectable amount of a full-length Tet protein was expressed. A polypeptide corresponding to the a domain was observed. Interdomain hybrids between tet(B) and tet(C) containing a frameshift at the fusion junction, designed to result in expression of each of the four domains on separate polypeptides, showed trans complementation without production of detectable full-length proteins. Levels of Tcr were greater than or equal to those previously observed in complementations using full-length hybrid proteins. These results strongly suggest that polypeptides harboring individual a and I8 domains, lacking an intact interdomain region, can interact productively in the cell to confer Tcr.
Tetracycline resistance (Tcr) among gram-negative bacteria is mediated by a family of related tet genes. To date, five Tcr determinant classes (A through E) have been identified (18, 20) , all of which show significant nucleotide and amino acid sequence homology (9, 21-23, 27, 29) . tet products are cytoplasmic membrane proteins which mediate energy-dependent export of tetracycline (16, 18, 19) . Their expression is under negative control by the tetR (repressor) product and subject to induction by tetracycline (2, 10, 12, 13, 32) . Products of class A and C tet [Tet(A) and Tet(C)] display 78% amino acid identity but have only 45% identity with the tet(B) product, Tet(B) (see, e.g., reference 29) .
Two intracistronic complementation groups, ot and , have been demonstrated in tet(B), corresponding respectively to the N-and C-terminal halves (ot and P domains) of Tet(B) (4) (5) (6) . These studies and other genetic analyses of Tet(B) suggest that Tet proteins occur as multimers in the cytoplasmic membrane in which ao and P domains from different polypeptides can function together (8) . That both domains are required for tetracycline efflux implies distinct (but as yet unknown) functions for each domain. However, sequence comparison of at and P domains strongly suggests that they have a common ancestor (25) . In-phase insertion mutagenesis of tet(C) has identified an interdomain region spanning at least codons 189 to 207, where insertions have minimal effect on activity (1) . The interdomain segment may in fact be substantially larger, e.g., amino acids 181 to 220, because the predicted sequence of Tet(B) diverges strongly (only 10% identity) from those of Tet(C) and Tet(A) throughout this region (29) . Restriction nuclease sites located in interdomain regions have been exploited to create interdomain hybrid genes in the tet family: a tet(A)altet(C) fusion expressing an interdomain hybrid protein confers high-level * Corresponding author.
Tcr, whereas tet(B)aI(C)3 and tet(C)a/(B)(3 interdomain hybrids express essentially inactive proteins (24) . However, expression of tet(B)a/(C)p and tet(C)a/(B)(3 in the same cell results in Tcr via trans complementation, verifying that, at a minimum, a functional at and a , domain from at least one Tet class (B or C) are being expressed (24) . Such findings indicate that specific interactions between a and a domains are necessary for high-level Tcr, requiring that both domains be supplied by closely related Tcr determinants [e.g., tet(A) and tet(C)].
Previous complementation analyses of tet have typically involved genes expressing inactive full-length proteins, e.g., two tet(B) mutants with each gene containing a presumed point mutation in a different domain (5) , or the hybrid analyses noted above. In such cases, levels of Tcr obtained by complementation have typically been 10 to 25% of that expressed by a wild-type tet gene. When one of the mutants used had a deletion in either domain, the level of complementing Tcr was only 2% of the wild-type level (5, 6) .
In this work, we have tested Tcr complementation by using gene constructions designed to express polypeptides containing single Tet domains which lack an intact interdomain region. Frameshift mutations which lead to expression of single-domain polypeptides were constructed and tested in tet(B) and in the interdomain hybrids tet(B)oaI(C)( and tet(C)aI(B)( [for brevity, tet(BIC) and tet(CIB)]. These genes were found to complement in trans at least as effectively as genes expressing full-length Tet hybrids.
MATERIALS AND METHODS
Bacterial strains and plasmids. Escherichia coli strains and plasmids used are listed in Table 1 . Plasmids constructed in this work are described in Table 2 . Restriction maps of some plasmids are shown in Fig. 1 . Growth conditions, media, and Gene constructions. General methods for transformation of E. coli, DNA isolation, and recombinant DNA manipulation have been described (17) .
(i) Construction of interdomain frameshift mutation in tet(B). A frameshift mutation at the EcoRI site in the interdomain region of wild-type tet(B) (on pRAR1020) was accomplished by cleavage with EcoRI nuclease, fill-in of the termini with Klenow DNA polymerase, and religation of the blunt termini (producing pRAR1045; Table 2 ). The expected new XmnI recognition site was verified by enzymatic cleavage. This 4-bp addition between the proximal and distal halves of tet(B) leads to termination of tet(B) after codon 200 at a nonsuppressed stop codon (TAA) (Fig. 2) . (Fig. 1) . Each hybrid determinant is carried on the Apr vector pRAR1011.
(iii) Inactivation of the tet(C)oa domain in a tet4(C)ao (B)4] hybrid. To inactivate tet(C)ot, the two-codon insertion mutation which eliminates Tcr in the constitutively expressed tet(C) of pFBI9 (1; Table 1 ; Fig. 1 ) was transferred in several steps to pRAR1030. First, the appropriate PstI-BamHI fragment in pRAR1009 was replaced with the corresponding one from pFBI9, producing pRAR1038 ( (Fig. 1) . XhoIBamHI fragment replacement from pRAR1039 into pRAR 1049 produced pRAR1050 {tet[(C)cx-(B)P3]}, which combines the mutations of pRAR1046 and pRAR1049 (Fig. 1) .
Tetracycline susceptibility assays. The MIC of tetracycline for plasmid-containing E. coli strains was determined by a gradient plate technique after induction of tet expression (24) .
Expression of plasmid-encoded proteins. Maxicells (26) were used to identify proteins specified by plasmids harbored in the recA strain BC32. Induction of gene expression in maxicells, labeling with [35S]methionine, fractionation of membrane and soluble proteins, sodium dodecyl sulfatepolyacrylamide gel electrophoresis (15) , and autoradiographic detection of labeled polypeptides were performed as described elsewhere (24) .
Tet-derived peptides were also detected in chlortetracycline-induced (24) logarithmic cultures of intact cells by using antibody as follows. After preparation of membrane fractions, proteins were resolved by polyacrylamide gel electrophoresis, blotted to Immobilon P (Millipore) according to the manufacturer's recommendations, and reacted with antibody to the N-terminal half of Tet(B) (gift of L. McMurry) or to the C-terminal half (gift of A. Yamaguchi [31] ) as described previously (7) . Antibody bound to the blot was detected by reaction with 125I-protein A (DuPont NEN) (7) and autoradiography. introduced by fill-in of the interdomain EcoRI site (producing plasmid pRAR1045) (Fig. 2) (Fig. 2) .
Tcr expressed by separate domains of frameshifted interdomain hybrids between tet(B) and tet(C). In pRAR1028 and pRAR1030 (24) , a frameshift occurring between the two halves of the hybrid tet reading frame in each case prevents expression of a full-length protein. As was found for hybrid genes specifying full-length Tet(B/C) or Tet(C/B) hybrids, these genes express essentially no Tcr (Table 3; 24) . Nevertheless, these frameshift hybrid tet genes {designated tet[(B)a -(C),B] and tet[ (C)a (B) ,B] or, for brevity, tet (B * C) and tet(C. B)} were capable of trans complementation when present in the same cell (Table 3 ). All complementation pairings involving tet(B -C) (pRAR1028) and/or tet(C B) (pRAR1030) yielded levels of Tcr equal to or substantially greater than those of pairings using only genes expressing the corresponding full-length hybrid proteins [tet(BIC) (pRAR1029) and tet(C/B) (pRAR1031)]. Similar patterns of Tcr were observed when the frameshift hybrid tet determinants were transferred from the Apr pBR322 replicon to a different multicopy vector, an oriP15A Cmr replicon (yielding pRAR1034 and pRAR1036, respectively; Tables 1  and 3 ). Because successful trans complementation involving any of the hybrids requires production of both an a and a a domain from the same determinant class (24) , one or both of the frameshift hybrid genes must be capable of expressing an intact a domain, presumably as a separate fragment by translation reinitiation.
Relative contributions of tet(C)a and tet(B)13 in trans complementation by a tet(C -B) hybrid gene. The ability of tet(C * B), when harboring inactivating mutations in one or both domains, to complement a tet(B/C) (pRAR1035) and a tet(B -C) (pRAR1034) hybrid was tested. An insertion of two codons into the tet(C)ot domain which is known to abolish activity of Tet(C) (1) was transferred into pRAR1030
[tet(C-B)], generating pRAR1046 {tet[(C)a--(B),B]}. This inactivation of the Tet(C) a domain had little or no effect on the level of Tcr complementation observed (Table 4) . Therefore, both pRAR1030 and pRAR1046 can express an active Tet(B)p domain, apparently as a single polypeptide (see above), and >90% of the observed Tcr is presumably due solely to productive Ba-B1 domain interactions.
An octamer insertion at the HpaI site of tet(B) (8) produced a 13 domain mutation. This alteration, which replaces the last 14 codons of tet(B) with 23 codons specifying a strongly basic peptide segment, reduces the level of Tcr by 75% (8) . When the tet(B),B+ mutation was transferred into pRAR1030, the resulting tet[(C)a+ (B),B+] mutant (on pRAR1049) was still capable of trans complementation, but the level of Tcr was c30% of that for pRAR1030 (Table 4) . Inactivation of tet(C)cx {producing pRAR1O50, tet [(C)a--(B),13]} had no additional effect on complementation, again indicating that Tet(C) domains did not contribute significantly to observed Tcr.
Incorporation of the tet(B)P'+ mutation into pRAR1045 {to produce pRAR1048, tet[(B)a+ * (B)P`+]} essentially eliminated Tcr (Table 4) . This finding contrasts with the partial Table 2 . Repressor gene (not indicated) and teta domain are always from the same determinant.
b Determined as described for Table 3 . Values are averages of two or more determinations (see Table 3 ). Ampicillin (25 ,ug/ml) and chloramphenicol (20 ,ug/ml) were present in the medium to ensure retention of both plasmid vectors. (24) ; polypeptides specific for the frameshift hybrid genes were not apparent (not shown).
When induced intact cells were used rather than maxicells, and Tet-derived peptides were detected by an antibody to the N-terminal half of Tet(B) (Materials and Methods), only polypeptides corresponding in size to the major bands in Fig. 3 (lane 1, 34 (5) . The truncated gene contains the first 201 codons of tet(B); the vector sequences to which it is fused contribute a single codon for glycine followed by a stop codon (TGA) which is not suppressed by the E. coli host used.
In this study, a mutant of tet(B) was constructed to contain both a frameshift and a terminator at the interdomain EcoRI site of pRAR1045 (Fig. 2) 
